David Allsop

Overview

Best Publications

• Amyloid deposition as the central event in the aetiology of Alzheimer's disease

  John Hardy;David Allsop

  3363
  Citations

• Magnetite pollution nanoparticles in the human brain.

  Barbara A. Maher;Imad A. M. Ahmed;Vassil Karloukovski;Donald A. MacLaren

  1058
  Citations

• Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

  Tobias Hartmann;Sophie C. Bieger;Babara Brühl;Pentti J. Tienari

  959
  Citations

• Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease

  Omar M. A. El-Agnaf;Sultan A. Salem;Katerina E. Paleologou;Martin D. Curran

  774
  Citations

• The occult aftermath of boxing.

  G W Roberts;D Allsop;C Bruton

  669
  Citations

• α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

  Omar M. A. El-Agnaf;Sultan A. Salem;Katerina E. Paleologou;Leanne J. Cooper

  661
  Citations

• Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease.

  Takahiko Tokuda;Sultan A. Salem;David Allsop;Toshiki Mizuno

  491
  Citations

• High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

  Hiroaki Fukumoto;Takahiko Tokuda;Takashi Kasai;Noriko Ishigami

  371
  Citations

• Inflammatory mechanisms in Alzheimer's disease

  P. Eikelenboom;Shan-Shan Zhan;W. A. Van Gool;D. Allsop

  357
  Citations

• Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease.

  Brian J. Tabner;Stuart Turnbull;Omar M.A. El-Agnaf;David Allsop

  350
  Citations

• Hydrogen Peroxide Is Generated during the Very Early Stages of Aggregation of the Amyloid Peptides Implicated in Alzheimer Disease and Familial British Dementia

  Brian J. Tabner;Omar M.A. El-Agnaf;Omar M.A. El-Agnaf;Stuart Turnbull;Matthew J. German

  292
  Citations

• Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.

  Harutsugu Tatebe;Takashi Kasai;Takuma Ohmichi;Yusuke Kishi

  277
  Citations

• Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

  Takashi Kasai;Takahiko Tokuda;Noriko Ishigami;Hiroshi Sasayama

  265
  Citations

• Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease

  Penelope G. Foulds;J. Douglas Mitchell;Angela Parker;Roisin Turner

  255
  Citations

• Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.

  Brian J. Tabner;Stuart Turnbull;Omar M.A. El-Agnaf;David Allsop

  245
  Citations

• Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

  Katerina E Paleologou;Christine L Kragh;David M A Mann;Sultan A Salem

  244
  Citations

• α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro.

  Stuart Turnbull;Brian J Tabner;Omar M.A El-Agnaf;Susan Moore

  233
  Citations

• A strategy for designing inhibitors of α -synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

  Omar M. A. El-Agnaf;Katerina E. Paleologou;Brett Greer;Abdulmawala M. Abogrein

  221
  Citations

• Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease

  D. Allsop;M. Landon;M. Kidd;J.S. Lowe

  203
  Citations

• TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration.

  Penelope Foulds;Erica McAuley;Linda Gibbons;Yvonne Davidson

  197
  Citations